Osteoporosis pp 145-149 | Cite as

An Introduction to Clinical Decision Making in Osteoporosis

  • Gordon H. Guyatt
Part of the Current Clinical Practice book series (CCP)


The decision to offer patients a particular treatment is rarely straightforward. In the area of osteoporosis, the choices are particularly complex. In clinical trials of osteoporosis, the outcomes that are easy to measure are of questionable importance, and the important outcomes occur infrequently and often far in the future. In the prevention of osteoporosis, the patient faces years of changes in lifestyle and possible side effects of medication, for a distant and uncertain outcome. In this chapter, I will outline the issues we should consider when offering a treatment recommendation. The discussion follows closely an approach my colleagues and I have offered in another publication(1).


Hormone Replacement Therapy Treatment Recommendation Relative Risk Reduction Target Event Absolute Risk Reduction 
These keywords were added by machine and not by the authors. This process is experimental and the keywords may be updated as the learning algorithm improves.


Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.


  1. 1.
    Guyatt GH, Sackett DL, Sinclair J. Hayward RS, Cook DJ, Cook TW. A method for grading health care recommendations.JAMA1995; 274: 1800–1804.PubMedCrossRefGoogle Scholar
  2. 2.
    Sinclair JC, Bracken MB. Clinically useful measures of effect in binary analyses of randomized trials.J Clin Epidemiol1994; 47: 881–889.PubMedCrossRefGoogle Scholar
  3. 3.
    Oxman AD, Cook DJ, Guyatt GH for the Evidence-Based Medicine Working Group. Users’ guides to the medical literature VI. How to use an overview.JAMA1994; 272: 1367–1371.PubMedCrossRefGoogle Scholar
  4. 4.
    Sacks HS, Chalmers TC, Smith H Jr. Sensitivity and specificity of clinical trials. Randomized versus historical assignment in controlled clinical trials.Arch Intern Med1983; 143: 753–755.PubMedCrossRefGoogle Scholar
  5. 5.
    Chalmers TC, Celano P, Sacks HS, Smith H Jr. Bias in treatment assignment in controlled clinical trials.NEngl J Med1983; 309: 1358–1361.CrossRefGoogle Scholar
  6. 6.
    Laupacis A, Sackett DL, Roberts RS. An assessment of clinically useful measures of the consequences of treatment.NEngl J Med1988; 318: 1728–1733.CrossRefGoogle Scholar
  7. 7.
    Guyatt GH, Sackett DL, Cook DJ and the Evidence-based Medicine Working Group. A users’ guide to the medical literature. How to use an article about therapy or prevention. Part B. What are the results and will they help me in caring for my patients.JAMA1994; 271: 59–63.PubMedCrossRefGoogle Scholar
  8. 8.
    Grady D, Rubin SM, Petitti DB, et al. Hormone therapy to prevent disease and prolong life in postmenopausal women.Ann Intern Med1992; 117: 1016–1037.PubMedGoogle Scholar

Copyright information

© Springer Science+Business Media New York 1996

Authors and Affiliations

  • Gordon H. Guyatt

There are no affiliations available

Personalised recommendations